Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.

Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, Fang JY, Gao CM, Götze T, Graziano F, Lacasaña-Navarro M, Lin D, López-Carrillo L, Qiao YL, Shen H, Stolzenberg-Solomon R, Takezaki T, Weng YR, Zhang FF, van Duijn CM, Boffetta P, Taioli E.

Am J Epidemiol. 2008 Mar 1;167(5):505-16. Epub 2007 Dec 27.

PMID:
18162478
2.

5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.

Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1956-63. Review.

3.
4.

Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis.

Wu YL, Hu CY, Lu SS, Gong FF, Feng F, Qian ZZ, Ding XX, Yang HY, Sun YH.

Metabolism. 2014 Dec;63(12):1503-11. Review.

PMID:
25458833
5.

Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review.

Sharp L, Little J.

Am J Epidemiol. 2004 Mar 1;159(5):423-43. Review.

PMID:
14977639
6.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.

Xia LZ, Liu Y, Xu XZ, Jiang PC, Ma G, Bu XF, Zhang YJ, Yu F, Xu KS, Li H.

World J Gastroenterol. 2014 Aug 28;20(32):11429-38. doi: 10.3748/wjg.v20.i32.11429. Review.

7.

A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children.

Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, Okcu MF.

Pediatr Blood Cancer. 2012 Apr;58(4):513-8. doi: 10.1002/pbc.23137. Epub 2011 Apr 14. Review.

PMID:
21495160
8.

5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

Botto LD, Yang Q.

Am J Epidemiol. 2000 May 1;151(9):862-77. Review.

PMID:
10791559
9.

The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.

Yi K, Yang L, Lan Z, Xi M.

Arch Gynecol Obstet. 2016 Sep;294(3):579-88. doi: 10.1007/s00404-016-4037-6. Epub 2016 Feb 15. Review.

PMID:
26879954
10.

Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.

Wu YL, Ding XX, Sun YH, Yang HY, Sun L.

J Neurol Sci. 2013 Dec 15;335(1-2):14-21. doi: 10.1016/j.jns.2013.09.006. Epub 2013 Sep 12. Review.

PMID:
24064257
11.

The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis.

van Beynum IM, den Heijer M, Blom HJ, Kapusta L.

QJM. 2007 Dec;100(12):743-53. Epub 2007 Oct 26. Review.

PMID:
17965089
12.

C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.

De Mattia E, Toffoli G.

Eur J Cancer. 2009 May;45(8):1333-51. doi: 10.1016/j.ejca.2008.12.004. Epub 2009 Jan 12. Review.

PMID:
19144510
13.

Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis.

Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M.

Mol Psychiatry. 2006 Feb;11(2):143-9. Review.

PMID:
16172608
14.

The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: a meta-analysis.

Liu H, Yang M, Li GM, Qiu Y, Zheng J, Du X, Wang JL, Liu RW.

J Neurol Sci. 2010 Jul 15;294(1-2):74-80. doi: 10.1016/j.jns.2010.04.001. Epub 2010 May 2. Review.

PMID:
20441995
15.

[Stroke and the genetics of hyperhomocysteinemia].

Nakamizo T, Nagayama M.

Brain Nerve. 2008 Nov;60(11):1295-306. Review. Japanese.

PMID:
19069163
16.

Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?

Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L; MTHFR in Psychiatry Group, de Hert M, Delespaul P, van Winkel R, Rutten BP.

Brain Behav Immun. 2011 Nov;25(8):1530-43. doi: 10.1016/j.bbi.2010.12.006. Epub 2010 Dec 24. Review.

PMID:
21185933
17.

Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.

Qi YH, Yao LP, Cui GB, Liang J, Shao QJ, Yan LF, Du P.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):172-80. doi: 10.1016/j.clinre.2013.10.002. Epub 2013 Dec 6. Review.

PMID:
24316043
18.

5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview.

Robien K, Ulrich CM.

Am J Epidemiol. 2003 Apr 1;157(7):571-82. Review.

PMID:
12672676
19.

Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review.

Kellen E, Hemelt M, Broberg K, Golka K, Kristensen VN, Hung RJ, Matullo G, Mittal RD, Porru S, Povey A, Schulz WA, Shen J, Buntinx F, Zeegers MP, Taioli E.

Am J Epidemiol. 2007 Jun 1;165(11):1221-30. Epub 2007 Apr 2. Review.

PMID:
17404387
20.

MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.

You W, Li Z, Jing C, Qian-Wei X, Yu-Ping Z, Weng-Guang L, Hua-Lei L.

DNA Cell Biol. 2013 May;32(5):260-7. doi: 10.1089/dna.2012.1931. Epub 2013 Apr 11. Review.

PMID:
23578207

Supplemental Content

Support Center